TXG logo

TXG

10x Genomics, Inc.NASDAQHealthcare
$22.33+1.27%ClosedMarket Cap: $2.85B

As of 2026-04-06

Valuation

View Details

P/E (TTM)

PEG

P/B

3.56

P/S

4.44

EV/EBITDA

-202.38

DCF Value

$-12.66

FCF Yield

4.6%

Div Yield

0.0%

Margins & Returns

Gross Margin

69.1%

Operating Margin

-9.5%

Net Margin

-6.8%

ROE

-5.7%

ROA

-4.5%

ROIC

-6.8%

Financials

View All
PeriodRevenueNet IncomeEPS
Q4 2025$166.0M$-16.3M$-0.13
FY 2025$642.8M$-43.5M$-0.35
Q3 2025$149.0M$-27.5M$-0.22
Q2 2025$172.9M$34.5M$0.28

Analyst Ratings

View All
William BlairOutperform
2026-03-31
StifelBuy
2026-03-02
UBSNeutral
2026-02-20
TD CowenHold
2026-02-13
Leerink PartnersMarket Perform
2026-01-27

Trading Activity

Insider Trades

View All
Saxonov Sergedirector, officer: Chief Executive Officer
SellWed Mar 25
Saxonov Sergedirector, officer: Chief Executive Officer
SellWed Mar 25
Saxonov Sergedirector, officer: Chief Executive Officer
SellWed Mar 04
Saxonov Sergedirector, officer: Chief Executive Officer
SellWed Mar 04
Saxonov Sergedirector, officer: Chief Executive Officer
SellWed Mar 04

Company Info

Sector

Healthcare

Industry

Country

US

Exchange

NASDAQ

Beta

2.17

10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity on a cell-by-cell basis; single cell immune profiling for measuring the activity of immune cells and their targets; single cell Assay for Transposase Accessible Chromati (ATAC) for measuring epigenetics comprising the physical organization of DNA; and single cell multiome ATAC + gene expression for measuring the genetic activity and epigenetic programming in the same cells across tens of thousands of cells in a single experiment. The company also provides visium spatial gene expression solution for measuring spatial gene expression patterns across a single tissue sample or gene expression and protein co-detection when combined with immunofluorescence. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.

Peers